Three new computational approaches enhance molecular property prediction and drug design through advanced neural networks, multimodal learning, and thermodynamic analysis of receptor-ligand interactions.
Clinical studies demonstrate GLP-1 receptor agonists like semaglutide and tirzepatide produce substantial weight loss when combined with lifestyle changes, with patients achieving mean reductions of 14.9% body weight over 68 weeks.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07195929 |
Determination of Blomia Tropicalis Allergen Extract in Prick Test Units |
NOT_YET_RECRUITING | NA |
| NCT06834165 |
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy |
RECRUITING | PHASE4 |
| NCT01204866 |
Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use |
COMPLETED | PHASE1 |
| NCT00894634 |
Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents |
COMPLETED | PHASE1 |
| NCT00837837 |
Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents |
COMPLETED | PHASE1 |
| NCT00195221 |
Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B |
COMPLETED |
